Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials

SH Kang, IH Chae, JJ Park, HS Lee, DY Kang… - Cardiovascular …, 2016 - jacc.org
Objectives This study sought to perform a systematic review and network meta-analysis to
compare the relative safety and efficacy of contemporary DES and BVS. Background To …

[HTML][HTML] Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences

A Mitsis, F Gragnano - Current cardiology reviews, 2021 - ncbi.nlm.nih.gov
Understanding the similarities and differences between myocardial infarction with or without
ST-segment elevation is an essential step for proper patients' management in current …

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta …

SH Kang, KW Park, DY Kang, WH Lim… - European heart …, 2014 - academic.oup.com
Background The aim of this study was to compare the safety and efficacy of biodegradable-
polymer (BP) drug-eluting stents (DES), bare metal stents (BMS), and durable-polymer DES …

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score …

S Brugaletta, T Gori, AF Low, P Tousek, E Pinar… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to compare the 1-year outcome between
bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic stent (EES) in ST …

Two-year outcomes after first-or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention …

M Valgimigli, M Tebaldi, M Borghesi, P Vranckx… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: This study sought to assess device-specific outcomes after implantation of bare-
metal stents (BMS), zotarolimus-eluting Endeavor Sprint stents (ZES-S), paclitaxel-eluting …

Reperfusion strategies in acute coronary syndromes

A Bagai, GD Dangas, GW Stone… - Circulation Research, 2014 - Am Heart Assoc
The appropriate timing of angiography to facilitate revascularization is essential to optimize
outcomes in patents with ST-segment–elevation myocardial infarction and non–ST-segment …

Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents

T Koppara, Q Cheng, K Yahagi, H Mori… - Circulation …, 2015 - Am Heart Assoc
Background—Acute thrombogenicity and re-endothelialization represent clinically relevant
end points pertaining to the safety of coronary stents, which have not been compared among …

Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a North American perspective—2016 update

DJ Angiolillo, SG Goodman, DL Bhatt… - Circulation …, 2016 - Am Heart Assoc
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation is an emerging clinical problem …

10-year follow-up of patients with everolimus-eluting versus bare-metal stents after ST-segment elevation myocardial infarction

S Brugaletta, J Gomez-Lara, L Ortega-Paz… - Journal of the American …, 2021 - jacc.org
Background Outcomes data for a durable-polymer everolimus-eluting stent (EES) at
extended long-term follow-up in patients with ST-segment elevation myocardial infarction …

Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the …

M Sabaté, L Räber, D Heg, S Brugaletta… - JACC: cardiovascular …, 2014 - jacc.org
Objectives: This study sought to study the efficacy and safety of newer-generation drug-
eluting stents (DES) compared with bare-metal stents (BMS) in an appropriately powered …